Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAn evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists
Clinical Therapeutics, 10/15/09
van Roon EN et al. – 40 potential drug–drug interactions (DDIs) with DMARDs were retrieved and assessed by the 2 groups. For 30 (75%) of these, rheumatologists and clinical pharmacists agreed about the requirement for immediate intervention. Specifically, 17 drug combinations (43%) were judged to interact and to require immediate intervention, and 13 combinations (33%) were judged either not to interact or to interact but not to require immediate intervention. For 10 combinations (25%), rheu–matologists and clinical pharmacists were not in agreement. Overall, agreement between the groups was good (? = 0.80) for judging whether the drug combinations were interactions, and agreement was fair (? = 0.39) for judging whether immediate intervention was required. Prospective analysis of the data showed that rheumatologists tended to recommend immediate intervention more often when the adverse reaction to the DDI involved an increased risk of tox–icity of the DMARD. In contrast, clinical pharmacists more often advocated immediate intervention when the adverse reaction involved decreased effectiveness of the DMARD.
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
A Randomized, Double-Blind Study Examining the Comparative Efficacies and Safety of Inhaled Epinephrine and Nasal Decongestant in Hospitalized Infants With Acute Bronchiolitis
The Pediatric Infectious Disease Journal, 11/17/09
Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia
Resuscitation, 11/18/09
Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials
Current Medical Research and Opinion, 10/27/09
Sponsor
Article Search
Sponsor